Literature DB >> 4206078

Plasma cell dyscrasia associated with the production of incomplete (?deleted) IgGlambda molecules, gamma heavy chains, and free lambda chains containing carbohydrate: description of the first case.

T Isobe, E F Osserman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4206078

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.

Authors:  W Feremans; M Caudron; C Bieva
Journal:  J Clin Pathol       Date:  1979-04       Impact factor: 3.411

Review 2.  gamma- and mu-Heavy chain diseases and related disorders.

Authors:  E C Franklin
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

3.  Immunochemical and ultrastructural study of multiple myeloma with a heavy chain protein in the serum.

Authors:  C Bartoloni; G Flamini; N Gentiloni; M A Russo; C Barone; G Gambassi; T Terranova
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

4.  Effect of immunoglobulins on mineral dust-induced production of reactive oxygen metabolites by human macrophages.

Authors:  P Nyberg; M Klockars
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

5.  IgG and IgA enhance the chrysotile-induced production of reactive oxygen metabolites by human polymorphonuclear leucocytes.

Authors:  M Klockars; M Hedenborg; J Koistinen; T Isobe
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

6.  Primary structure of a deleted human lambda type immunoglobulin light chain containing carbohydrate: protein Sm lambda.

Authors:  F A Garver; L Chang; J Mendicino; T Isobe; E F Osserman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

7.  Deleted IgG1 and IgG2 H chains in a patient with an IgG subclass imbalance.

Authors:  J P Lebreton; M Fontaine; J Rousseaux; P Youinou; D Hurez; L Rivat-Peran; J P Bernards
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.